TY - JOUR
T1 - Metabolism of 15-hydroxyeicosatetraenoic acid by Caco-2 cells
AU - Riehl, T. E.
AU - Bass, N. M.
AU - Stenson, W. F.
PY - 1990
Y1 - 1990
N2 - Monolayers of Caco-2 cells, a human enterocyte cell line, were incubated with [1-14C]15-hydroxyeicosatetraenoic acid (15-HETE), a lipid mediator of inflammation, and [1-14C]arachidonic acid. Both fatty acids were taken up readily and metabolized by Caco-2 cells. [1-14C]Arachidonic acid was directly esterified in cellular phospholipids and, to a lesser extent, in triglycerides. When [1-14C]15-hydroxyeicosatetraenoic acid was incubated with Caco-2 cells, about 10% was directly esterified into cellular lipids but most (55%) was β-oxidized to ketone bodies, CO2, and acetate, with very little accumulation of shorter carbon chain products of partial β-oxidation. The radiolabeled acetate generated from β-oxidation of [1-14C]15-hydroxyeicosatetraenoic acid was incorporated into the synthesis of new fatty acids, primarily [14C]palmitate, which in turn was esterified into cellular phospholipids, with lesser amounts in triglycerides. Caco-2 cells were also incubated with [5,6,8,9,11,12,14,15-3H]15-hydroxyeicosatetraenoic acid; most of the radiolabel was recovered either in ketone bodies or in [3H]palmitate esterified in phospholipids and triglycerides, demonstrating that most of the [3H]15-hydroxyeicosatetraenoic acid underwent several cycles of β-oxidation. The binding of both 15-hydroxyeicosatetraenoic acid and arachidonic acid to hepatic fatty acid binding protein, the only fatty acid binding protein in Caco-2 cells, was measured. The K(d) (6.0 μM) for 15-HETE was three-fold higher than that for arachidonate (2.1 μM).
AB - Monolayers of Caco-2 cells, a human enterocyte cell line, were incubated with [1-14C]15-hydroxyeicosatetraenoic acid (15-HETE), a lipid mediator of inflammation, and [1-14C]arachidonic acid. Both fatty acids were taken up readily and metabolized by Caco-2 cells. [1-14C]Arachidonic acid was directly esterified in cellular phospholipids and, to a lesser extent, in triglycerides. When [1-14C]15-hydroxyeicosatetraenoic acid was incubated with Caco-2 cells, about 10% was directly esterified into cellular lipids but most (55%) was β-oxidized to ketone bodies, CO2, and acetate, with very little accumulation of shorter carbon chain products of partial β-oxidation. The radiolabeled acetate generated from β-oxidation of [1-14C]15-hydroxyeicosatetraenoic acid was incorporated into the synthesis of new fatty acids, primarily [14C]palmitate, which in turn was esterified into cellular phospholipids, with lesser amounts in triglycerides. Caco-2 cells were also incubated with [5,6,8,9,11,12,14,15-3H]15-hydroxyeicosatetraenoic acid; most of the radiolabel was recovered either in ketone bodies or in [3H]palmitate esterified in phospholipids and triglycerides, demonstrating that most of the [3H]15-hydroxyeicosatetraenoic acid underwent several cycles of β-oxidation. The binding of both 15-hydroxyeicosatetraenoic acid and arachidonic acid to hepatic fatty acid binding protein, the only fatty acid binding protein in Caco-2 cells, was measured. The K(d) (6.0 μM) for 15-HETE was three-fold higher than that for arachidonate (2.1 μM).
KW - 15-HETE
KW - inflammatory bowel disease
KW - β-oxidation
UR - http://www.scopus.com/inward/record.url?scp=0025280434&partnerID=8YFLogxK
M3 - Article
C2 - 2116490
AN - SCOPUS:0025280434
SN - 0022-2275
VL - 31
SP - 773
EP - 780
JO - Journal of Lipid Research
JF - Journal of Lipid Research
IS - 5
ER -